,name,id,smiles,formula
0,(beta)-agonists,None,None,None
1,"3-hydroxy-1,4-benzodiazepine",DB00778,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,C41H76N2O15
2,5-ht1 agonists,DB08839,C1=CC2=C(C=C1O)C(=CN2)CCN,C10H12N2O
3,5-ht1b/1d agonists,DB08839,C1=CC2=C(C=C1O)C(=CN2)CCN,C10H12N2O
4,5-ht3 antagonists,DB08839,C1=CC2=C(C=C1O)C(=CN2)CCN,C10H12N2O
5,5-ht3 antiemetics,DB08839,C1=CC2=C(C=C1O)C(=CN2)CCN,C10H12N2O
6,5ht3 antagonists,None,None,None
7,5ht3 antagonist class,None,None,None
8,ace inhibitors,None,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@@H]7CCC(=O)N7,None
9,ace inhibitor,None,CCC(C)C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCN=C(N)N)NC(=O)C4CCCN4C(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C7CCC(=O)N7,None
10,ace-inhibitors,None,None,None
11,acei,DB09495,CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC,C20H22O3
12,acth,DB01285,None,C207H308N56O58S
13,aed,DB00115,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](/C(=C(/C7=N/C(=C\C8=N/C(=C(\C4=N5)/C)/[C@H](C8(C)C)CCC(=O)N)/[C@H]([C@]7(C)CC(=O)N)CCC(=O)N)\C)/[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],C63H88CoN14O14P
14,aeds,None,None,None
15,anesthetics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
16,antacid,DB01377,[O-2].[Mg+2],MgO
17,arb,DB00012,None,C815H1317N233O241S5
18,acellular vaccines,None,None,None
19,acidifying agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
20,adrenal steroids,DB00584,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,C20H28N2O5
21,adrenergic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
22,adrenergic blockers,None,None,None
23,agents with b-blocking properties,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
24,agonist/antagonist analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
25,alpha-adrenergic blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
26,alpha-blockers,DB11105,None,None
27,aminoglycosides,DB15258,None,C1575H2400N422O477S6
28,amphetamines,DB00182,CC(CC1=CC=CC=C1)N,C9H13N
29,anabolic steroids,None,None,None
30,analgesic,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
31,angiotensin converting enzyme (ace) inhibitors,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
32,angiotensin ii receptor antagonists,DB11842,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,None
33,angiotensln converting enzyme inhibitors,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
34,antacid products,DB01377,[O-2].[Mg+2],MgO
35,antacids,DB01377,[O-2].[Mg+2],MgO
36,anti-hiv protease inhibitors,DB09075,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,C24H30ClN7O4S
37,anti-migraine,None,None,None
38,anti-arrhythmics,None,None,None
39,antiarrhythmics,None,None,None
40,antibiotics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
41,anticholinergic agents,DB00122,C[N+](C)(C)CCO,C5H14NO
42,anticholinergic drugs,DB00122,C[N+](C)(C)CCO,C5H14NO
43,anticholinergics,DB00122,C[N+](C)(C)CCO,C5H14NO
44,anticholinesterases,DB00122,C[N+](C)(C)CCO,C5H14NO
45,anticoagulants,None,None,None
46,anticonvulsants,DB00555,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C9H7Cl2N5
47,antidepressant,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
48,antidepressants,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
49,antidiabetic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
50,antidiabetic drug,None,None,None
51,antidiabetic drugs,None,None,None
52,antidiabetics,None,None,None
53,antiepileptic drugs,None,None,None
54,antifungal,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
55,antifungals,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
56,antihistamines,DB05381,C1=C(NC=N1)CCN,C5H9N3
57,antihypertensive,None,None,None
58,antihypertensive medication,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
59,antihypertensive medications,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
60,antihypertensives,None,None,None
61,antimycobacterial,None,None,None
62,antimycobacterial agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
63,antineoplastic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
64,antiplatelet agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
65,antiplatelets,None,None,None
66,antipsychotic drugs,None,None,None
67,antiretroviral,DB00495,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],C10H13N5O4
68,antiretroviral agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
69,antiretroviral drugs,DB00495,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],C10H13N5O4
70,antithrombotics,None,None,None
71,antithyroid agents,DB00279,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,C15H12I3NO4
72,azole antifungals,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
73,barbiturates,DB08844,C12=C(NC(=O)N1)NC(=O)NC2=O,C5H4N4O3
74,bacteriostatic antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
75,benzodiazepines,DB12537,C1=CC=C2C(=C1)C=CC=NN2,C9H8N2
76,beta blockers,None,None,None
77,beta adrenergic agonists,None,None,None
78,beta-blockers,None,None,None
79,beta-adrenergic blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
80,beta-adrenergic blocking drugs,None,None,None
81,beta-adrenergic receptor antagonists,None,None,None
82,beta-blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
83,bile acid binding resins,None,None,None
84,broad-spectrum antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
85,butyrophenones,DB14076,None,None
86,central nervous system depressants,DB06787,C[N+]1(CCN(CC1)CC(C2CCCCC2)(C3=CC=CC=C3)O)C,C20H33N2O
87,cns depressants,None,None,None
88,cns depressant,None,None,None
89,cns depressant drugs,None,None,None
90,cns depressant medications,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
91,cns depression-producing drugs,None,None,None
92,cns stimulants,None,None,None
93,cns-depressant drug,None,None,None
94,coumarin anticoagulants,DB04665,C1=CC=C2C(=C1)C=CC(=O)O2,C9H6O2
95,calcium antagonist,DB01373,[Ca],Ca
96,calcium channel blockers,DB01373,[Ca],Ca
97,calcium channel blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
98,cardiac glycosides,DB15258,None,C1575H2400N422O477S6
99,catecholamine-depleting drugs,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
100,central nervous system depressant,DB06787,C[N+]1(CCN(CC1)CC(C2CCCCC2)(C3=CC=CC=C3)O)C,C20H33N2O
101,cephalosporins,None,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CCC[C@H](C(=O)O)N)SC1)C(=O)O,None
102,cholinesterase inhibitors,DB00122,C[N+](C)(C)CCO,C5H14NO
103,cholinomimetics,DB00315,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3,C16H21N3O2
104,combination oral contraceptives,None,None,None
105,combination hormonal contraceptives,None,None,None
106,contraceptive,DB00367,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,C21H28O2
107,contraceptives,None,None,None
108,corticosteroids,None,C[C@@H]1C[C@H]2[C@@H]3C=C(C4=CC5=C(C[C@@]4([C@H]3[C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)C)C=NN5C6=CC=CC=C6)C,None
109,coumarin anticoagulant,DB04665,C1=CC=C2C(=C1)C=CC(=O)O2,C9H6O2
110,coumarin-derivative anticoagulants,DB04665,C1=CC=C2C(=C1)C=CC(=O)O2,C9H6O2
111,coumarin-type anticoagulants,DB04665,C1=CC=C2C(=C1)C=CC(=O)O2,C9H6O2
112,curariform drugs,None,None,None
113,cytokines,None,None,None
114,cytotoxic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
115,digitalis,DB00076,None,C2085H3223N553O672S16
116,digitalis glycosides,DB15258,None,C1575H2400N422O477S6
117,dihydropyridine,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
118,diuretic,None,None,None
119,diuretic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
120,diuretics,None,None,None
121,dopamine antagonists,DB00462,C[N+]1([C@H]2CC(C[C@H]1C3C2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C.[Br-],C18H24BrNO4
122,dopamine d2 receptor antagonists,DB00462,C[N+]1([C@H]2CC(C[C@H]1C3C2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C.[Br-],C18H24BrNO4
123,ergot derivatives,None,None,None
124,estrogen,DB00286,None,None
125,estrogens,DB00286,None,None
126,fat-soluble vitamin supplements,DB05830,C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@@H]3[C@@H]1[C@@H]4CC[C@@H]([C@]4(CC3)C)O,C19H28O2
127,fibrates,None,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,None
128,fibric acid derivatives,None,None,None
129,gastrointestinal acidifying agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
130,h 2 -receptor antagonists,None,None,None
131,h 2 receptor antagonists,None,None,None
132,h1 blockers,None,None,None
133,h1-blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
134,h2 blockers,None,None,None
135,h2 receptor antagonists,None,None,None
136,h2 antagonists,None,None,None
137,h2-receptor antagonists,None,None,None
138,h2-antagonists,None,None,None
139,hdac inhibitors,None,CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CCCCNC(=O)C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)C,None
140,hiv protease inhibitors,DB09075,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,C24H30ClN7O4S
141,hiv-protease inhibitors,DB00818,CC(C)C1=C(C(=CC=C1)C(C)C)O,C12H18O
142,hmg-coa reductase inhibitor,None,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,None
143,hmg-coa reductase inhibitors,None,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,None
144,hmg-coa reductase inhibitor class,None,None,None
145,hmgcoa reductase inhibitors,None,None,None
146,histamine h2 antagonists,DB05381,C1=C(NC=N1)CCN,C5H9N3
147,histamine h2-receptor antagonists,DB05381,C1=C(NC=N1)CCN,C5H9N3
148,hormonal contraceptives,None,None,None
149,hypnotics,None,None,None
150,hypoglycemic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
151,hypoglycemics,DB06724,C(=O)([O-])[O-].[Ca+2],CCaO3
152,imidazoles,DB00819,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C4H6N4O3S2
153,immunosuppressants,None,None,None
154,immunosuppressive drugs,None,None,None
155,inhibitors of hmg-coa reductase,None,None,None
156,intestinal adsorbents,None,None,None
157,iodinated contrast media,DB00554,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,C15H13N3O4S
158,iron supplements,DB00115,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](/C(=C(/C7=N/C(=C\C8=N/C(=C(\C4=N5)/C)/[C@H](C8(C)C)CCC(=O)N)/[C@H]([C@]7(C)CC(=O)N)CCC(=O)N)\C)/[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],C63H88CoN14O14P
159,killed virus vaccines,None,None,None
160,live vaccines,None,None,None
161,live virus vaccines,None,None,None
162,loop diuretics,None,None,None
163,mao inhibitors,None,None,None
164,mao inhibitor,None,None,None
165,mao-a inhibitors,None,None,None
166,mao-b inhibitor,None,None,None
167,mao-inhibitors,None,None,None
168,maoi,None,None,None
169,maoi antidepressants,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
170,maois,None,None,None
171,macrolide antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
172,macrolides,DB00778,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,C41H76N2O15
173,methylxanthines,DB02134,C1=NC2=C(N1)C(=O)NC(=O)N2,C5H4N4O2
174,mixed agonist/antagonist opioid analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
175,monoamine oxidase inhibitors,None,None,None
176,monoamine oxidase (mao) inhibitors,None,None,None
177,multivitamins,DB00115,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](/C(=C(/C7=N/C(=C\C8=N/C(=C(\C4=N5)/C)/[C@H](C8(C)C)CCC(=O)N)/[C@H]([C@]7(C)CC(=O)N)CCC(=O)N)\C)/[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],C63H88CoN14O14P
178,narcotic analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
179,narcotics,None,None,None
180,nnrti,None,None,None
181,nnrtis,None,None,None
182,non-narcotic analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
183,nrtis,None,None,None
184,nsaid,DB00201,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,C8H10N4O2
185,nsaids,None,None,None
186,neuroleptic,None,None,None
187,neuroleptic drugs,None,None,None
188,neuromuscular blockers,None,None,None
189,neuromuscular blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
190,nitrates,DB14049,[N+](=O)([O-])[O-],NO3
191,non-steroidal anti-inflammatory drugs,None,None,None
192,non-nucleoside reverse transcriptase inhibitors,None,None,None
193,non-selective mao inhibitors,None,None,None
194,non-selective monoamine oxidase (mao) inhibitors,None,None,None
195,non-steroidal anti-inflammatory agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
196,noncardioselective beta-blockers,None,None,None
197,nondepolarizing muscle relaxants,DB00452,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N,C23H46N6O13
198,nonsteroidal anti-inflammatory drugs,None,None,None
199,nonsteroidal antiinflammatory drug,None,None,None
200,nonsteroidal anti-inflammatory agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
201,ocs,DB09321,O=[Zn],OZn
202,opioids,DB11130,None,None
203,phenothiazines,DB00207,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,C38H72N2O12
204,pi,DB00001,None,C287H440N80O111S6
205,poc,DB00016,None,C815H1317N233O241S5
206,ppis,None,None,None
207,penicillin,DB00301,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,C19H17ClFN3O5S
208,phenothiazine-related compounds,DB00207,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,C38H72N2O12
209,platelet inhibitors,None,None,None
210,potassium-sparing diuretics,DB14500,[K],K
211,potassium-depleting diuretics,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
212,protease inhibitors,DB09075,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,C24H30ClN7O4S
213,protease inhibitor,DB00058,None,C2001H3130N514O601S10
214,proton pump inhibitors,None,None,None
215,psychoactive drugs,DB03166,CC(=O)O,C2H4O2
216,pyrazolone derivatives,DB00819,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C4H6N4O3S2
217,quinolone antibiotic,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
218,quinolones,DB09526,C1=CC(=CC=C1O)O,C6H6O2
219,resin,DB00035,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N,C46H64N14O12S2
220,resins,DB11131,None,C18H27NO3
221,salicylate drugs,DB00979,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,C17H25NO3
222,sedative-hypnotics,None,None,None
223,ssri,None,None,None
224,ssri antidepressants,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
225,ssris,None,None,None
226,salicylate,DB00233,C1=CC(=C(C=C1N)O)C(=O)O,C7H7NO3
227,salicylates,DB00979,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,C17H25NO3
228,sedative,DB01323,None,None
229,sedatives,None,None,None
230,selective serotonin reuptake inhibitors,DB08839,C1=CC2=C(C=C1O)C(=CN2)CCN,C10H12N2O
231,serotonergic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
232,short-acting beta2-agonists,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
233,short-acting benzodiazepines,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
234,skeletal muscle relaxants,DB09287,None,None
235,slow-channel calcium blockers,DB01373,[Ca],Ca
236,statins,DB06423,None,None
237,steroids,DB11325,None,None
238,sulfonamides,DB15258,None,C1575H2400N422O477S6
239,sulfonylureas,DB03904,C(=O)(N)N,CH4N2O
240,sympathomimetic amines,None,None,None
241,sympathomimetics,None,None,None
242,systemic corticosteroids,None,None,None
243,t.a.,DB00162,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,C20H30O
244,tca,DB00267,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,C16H17N9O5S3
245,tcas,None,C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,None
246,tnf antagonist,None,None,None
247,tnf antagonists,None,None,None
248,tnf blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
249,tnf-blocking agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
250,tnf-blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
251,tnfa-blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
252,tranquilizers,DB00683,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,C18H13ClFN3
253,tricyclic antidepressants,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
254,tetracycline,DB00759,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,C22H24N2O8
255,tetracyclines,DB00759,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,C22H24N2O8
256,thiazide diuretics,None,None,None
257,thiazide drugs,None,None,None
258,thiazides,DB15258,None,C1575H2400N422O477S6
259,thrombolytic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
260,thyroid,DB00279,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,C15H12I3NO4
261,thyroid hormones,DB00279,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,C15H12I3NO4
262,thyroid preparations,DB00279,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,C15H12I3NO4
263,type 1c antiarrhythmics,None,None,None
264,uricosuric agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
265,uricosuric drugs,None,None,None
266,urinary acidifying agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
267,vaccines,DB09145,O,H2O
268,vasoconstrictors,DB06711,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,C14H14N2
269,vasodilators,None,None,None
270,vasopressor,None,None,None
271,vasopressors,None,None,None
272,veratrum alkaloids,None,None,None
273,vitamin a,DB00162,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,C20H30O
274,vitamin d,DB00153,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,C28H44O
275,vitamin k,DB01022,CC1=C(C(=O)C2=CC=CC=C2C1=O)C/C=C(\C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C,C31H46O2
276,absorbent-type anti-diarrhea medicines,DB00507,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],C12H9N3O5S
277,activated prothrombin complex concentrates,DB00898,CCO,C2H6O
278,adrenal cortical steroids,DB00584,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,C20H28N2O5
279,adrenergic,None,None,None
280,adrenergic agonists,None,None,None
281,adrenergic beta-receptor blockers,None,None,None
282,adrenergic bronchodilators,DB12846,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O,C18H23N5O5
283,adrenergic drugs,None,None,None
284,adrenergic neuron blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
285,adrenocortical steroid,None,None,None
286,adrenocortical steroids,None,None,None
287,alkalinizing agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
288,alpha glucosidase inhibitors,DB11105,None,None
289,alpha-2 agonists,DB11105,None,None
290,alpha-adrenergic stimulants,DB11105,None,None
291,alpha-blocker,DB11105,None,None
292,aluminum/magnesium hydroxide antacids,DB00778,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,C41H76N2O15
293,amide-type local anesthetics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
294,aminoglycoside,None,None,None
295,aminoglycoside antibiotic,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
296,aminoglycoside antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
297,aminoglycosidic antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
298,aminosalicylate derivatives,DB00979,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,C17H25NO3
299,amphetamine,DB00182,CC(CC1=CC=CC=C1)N,C9H13N
300,anabolic hormones,None,None,None
301,analgesic adjuvants,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
302,analgesic agents,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
303,analgesic drugs,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
304,analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
305,androgen,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
306,androgens,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
307,anesthetic,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
308,anesthetic agents,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
309,anesthetic solutions,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
310,angiotensin converting enzyme inhibitors,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
311,angiotensin- converting enzyme (ace) inhibitors,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
312,angiotensin-converting enzyme (ace) inhibitors,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
313,angiotensin-converting enzyme inhibitor,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
314,angiotensin-converting enzyme inhibitors,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
315,anion exchange resin,None,None,None
316,anion-exchange resins,None,None,None
317,anionic exchange resins,DB11057,None,None
318,antacid preparations,DB01377,[O-2].[Mg+2],MgO
319,anti platelet agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
320,anti-anxiety drugs,None,None,None
321,anti-arrhythmic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
322,anti-cancer drugs,None,None,None
323,anti-coagulants,None,None,None
324,anti-depressants,None,None,None
325,anti-helminthic,DB00898,CCO,C2H6O
326,anti-hypertensive drug,None,None,None
327,anti-hypertensives,None,None,None
328,anti-infective medicines,None,None,None
329,anti-inflammatory,DB00297,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,C18H28N2O
330,anti-malarial drugs,DB00938,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,C25H37NO4
331,anti-parkinsonian drug,DB00376,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,C20H31NO
332,anti-pseudomonal antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
333,anti-ulcer,None,None,None
334,antianginals,None,None,None
335,antianxiety agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
336,antianxiety drugs,None,None,None
337,antiarrhythmic agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
338,antiarrhythmic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
339,antiarrhythmic agents of class i,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
340,antiarrhythmic drugs,None,None,None
341,antibacterial,DB00898,CCO,C2H6O
342,antibacterial drug,DB00898,CCO,C2H6O
343,antibacterial drugs,DB00898,CCO,C2H6O
344,antibiotic,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
345,antibiotic drug,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
346,antibodies,DB14115,None,None
347,anticancer agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
348,antichlolinergic,None,None,None
349,anticholinergic,DB00122,C[N+](C)(C)CCO,C5H14NO
350,anticholinergic agent,DB00122,C[N+](C)(C)CCO,C5H14NO
351,anticholinergic compounds,DB00122,C[N+](C)(C)CCO,C5H14NO
352,anticholinergic medications,DB00122,C[N+](C)(C)CCO,C5H14NO
353,anticholinesterase,DB00122,C[N+](C)(C)CCO,C5H14NO
354,anticholinesterase agents,DB00122,C[N+](C)(C)CCO,C5H14NO
355,anticoagulant,DB00173,C1=NC2=NC=NC(=C2N1)N,C5H5N5
356,anticoagulant agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
357,anticoagulant drugs,None,None,None
358,anticoagulant medication,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
359,anticoagulants of the coumarin type,DB04665,C1=CC=C2C(=C1)C=CC(=O)O2,C9H6O2
360,anticoagulants of the warfarin type,DB00682,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,C19H16O4
361,anticonvulsant,DB00555,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C9H7Cl2N5
362,anticonvulsant agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
363,anticonvulsant drugs,DB00555,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C9H7Cl2N5
364,anticonvulsant medications,DB00555,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C9H7Cl2N5
365,antidepressant drug,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
366,antidepressant drugs,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
367,antidepressants of the mao inhibitor class,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
368,antidiabetic agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
369,antidiabetic medication,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
370,antidiabetic products,None,None,None
371,antiemetics,None,None,None
372,antiepileptic medications,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
373,antiestrogen,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
374,antiestrogens,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
375,antifungal agents,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
376,antifungal drug,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
377,antiglaucoma agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
378,antigout drugs,None,None,None
379,antihistaminics,None,None,None
380,antihyperlipidemics,None,None,None
381,antihypertensive agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
382,antihypertensive compounds,None,None,None
383,antihypertensive drugs,None,None,None
384,antimalarials,DB00938,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,C25H37NO4
385,antimuscarinics,DB11074,None,None
386,antimycotic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
387,antineoplastic drugs,None,None,None
388,antiparkinson drugs,DB00376,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,C20H31NO
389,antiparkinsonian agents,DB00376,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,C20H31NO
390,antiparkinsonian drug,DB00376,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,C20H31NO
391,antiparkinsonian-agents,DB00376,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,C20H31NO
392,antiplatelet drug,None,None,None
393,antiplatelet medication,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
394,antipsychotic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
395,antipsychotic drug,None,None,None
396,antipsychotic medications,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
397,antipsychotics,None,None,None
398,antipyretics,None,None,None
399,antiretroviral medication,DB00495,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],C10H13N5O4
400,antiretroviral medications,DB00495,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],C10H13N5O4
401,antithrombotic agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
402,antithyroid drugs,DB00279,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,C15H12I3NO4
403,antituberculosis drug,None,None,None
404,antituberculous drugs,None,None,None
405,antivirals,None,None,None
406,anxiolytic,None,None,None
407,anxiolytics,None,None,None
408,atypical antipsychotic,None,None,None
409,atypical neuroleptic,None,None,None
410,avian influenza vaccines,None,None,None
411,azole antifungal,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
412,azole antifungal agents,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
413,azole antimycotics,DB00819,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C4H6N4O3S2
414,azole-type antifungal agents,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
415,azoles,DB00819,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C4H6N4O3S2
416,b-adrenergic blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
417,b-blocking agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
418,b-blocking drug,None,None,None
419,b-lactam antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
420,b-lactams,None,C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O,None
421,bacitracin,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
422,bacteriostatic antibiotic,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
423,barbituates,None,None,None
424,belladonna alkaloids,DB00424,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3,C17H23NO3
425,benzodiazepenes,None,None,None
426,benzodiazepine,DB12537,C1=CC=C2C(=C1)C=CC=NN2,C9H8N2
427,benzodiazepine class,DB12537,C1=CC=C2C(=C1)C=CC=NN2,C9H8N2
428,benzothiadiazines,DB00207,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,C38H72N2O12
429,benzothiazepine,None,C1=CC=C2C(=C1)C=CC=NS2,None
430,beta adrenergic aerosol bronchodilators,DB12846,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O,C18H23N5O5
431,beta adrenergic antagonists,None,None,None
432,beta adrenergic blockers,None,None,None
433,beta adrenergic blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
434,beta adrenergic-blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
435,beta blocker,None,None,None
436,beta blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
437,beta-adrenergic antagonists,None,None,None
438,beta-adrenergic blocker,None,None,None
439,beta-adrenergic blockers,None,None,None
440,beta-adrenergic blocking agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
441,beta-adrenergic receptor blockers,None,None,None
442,beta-adrenergic receptor blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
443,beta-adrenergic-blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
444,beta-adrenoceptor blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
445,beta-agonist,None,None,None
446,beta-agonists,None,None,None
447,beta-blocker,None,None,None
448,beta-blocking agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
449,beta-lactam antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
450,beta-receptor blockers,None,None,None
451,beta2 agonists,None,None,None
452,beta2-agonist,None,None,None
453,beta2-agonists,None,None,None
454,beta2-agonists.,None,None,None
455,betablockers,None,None,None
456,biguanides,DB13100,C(=NC(=N)N)(N)N,C2H7N5
457,bile acid binding resin,None,None,None
458,bile acid sequestrants,DB01432,None,None
459,bisphosphonates,None,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,None
460,blood thinner,None,None,None
461,botulinum toxin,DB00042,None,None
462,bronchodilators,DB12846,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O,C18H23N5O5
463,butyrophenone classes of antipsychotic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
464,calcineurin inhibitor,None,None,None
465,calcium antagonists,DB01373,[Ca],Ca
466,calcium blockers,DB01373,[Ca],Ca
467,calcium channel antagonists,DB01373,[Ca],Ca
468,calcium channel blocker,DB01373,[Ca],Ca
469,calcium channel blocking drugs,DB01373,[Ca],Ca
470,calcium channel-blockers,DB01373,[Ca],Ca
471,calcium channel-blocking drugs,DB01373,[Ca],Ca
472,calcium-blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
473,calcium-channel blockers,DB01373,[Ca],Ca
474,calcium-channel-blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
475,calcium-entry blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
476,cannabinoids,None,CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O.CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,None
477,carbonic anhydrase inhibitor,DB09278,C,C
478,carbonic anhydrase inhibitors,DB09278,C,C
479,cardioselective beta-blocker,None,None,None
480,catecholamine depletors,None,None,None
481,catecholamines,None,C1=CC(=C(C(=C1)O)O)N,None
482,central nervous system (cns) depressants,DB06787,C[N+]1(CCN(CC1)CC(C2CCCCC2)(C3=CC=CC=C3)O)C,C20H33N2O
483,central nervous system stimulants,DB06787,C[N+]1(CCN(CC1)CC(C2CCCCC2)(C3=CC=CC=C3)O)C,C20H33N2O
484,centrally acting drugs,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
485,cephalosporin,DB00456,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O,C16H16N2O6S2
486,cephalosporin antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
487,chemotherapeutic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
488,chlorpheniramine,DB01114,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,C16H19ClN2
489,cholinergic agonists,DB00122,C[N+](C)(C)CCO,C5H14NO
490,coagulation factor,DB00025,None,C11794H18314N3220O3553S83
491,combined oral contraceptives,None,None,None
492,contraceptive agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
493,contraceptive product,None,None,None
494,coronary vasodilators,None,None,None
495,cortico-steroids,None,None,None
496,corticosteroid,DB00297,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,C18H28N2O
497,coumarin,DB04665,C1=CC=C2C(=C1)C=CC(=O)O2,C9H6O2
498,coumarin derivatives,DB04665,C1=CC=C2C(=C1)C=CC(=O)O2,C9H6O2
499,coumarin drugs,DB04665,C1=CC=C2C(=C1)C=CC(=O)O2,C9H6O2
500,coumarins,DB04665,C1=CC=C2C(=C1)C=CC(=O)O2,C9H6O2
501,curare-like compounds,None,None,None
502,cyclic antidepressants,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
503,cyclooxygenase-2 inhibitors,DB09140,O=O,O2
504,cytostatic agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
505,cytotoxic,DB15559,None,None
506,decongestant drugs,DB00286,None,None
507,decongestants,DB00286,None,None
508,delta(1)-selective opioids,DB11130,None,None
509,diagnostic monoclonal antibodies,None,None,None
510,digestive enzyme preparations,DB09321,O=[Zn],OZn
511,digitalis glycoside,None,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,None
512,digitalis preparations,DB09321,O=[Zn],OZn
513,dihydropyridine calcium antagonists,DB00898,CCO,C2H6O
514,dihydropyridine calcium channel blockers,DB00898,CCO,C2H6O
515,dihydropyridine derivative,DB00898,CCO,C2H6O
516,diphosphonate,DB00720,C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl,CH4Cl2O6P2
517,dopa decarboxylase inhibitor,DB00776,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,C15H12N2O2
518,dopa-decarboxylase inhibitor,DB00776,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,C15H12N2O2
519,dopamine agonist,DB00462,C[N+]1([C@H]2CC(C[C@H]1C3C2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C.[Br-],C18H24BrNO4
520,dopamine agonists,DB00462,C[N+]1([C@H]2CC(C[C@H]1C3C2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C.[Br-],C18H24BrNO4
521,dopaminergic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
522,emetic,DB00662,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,C21H28N2O5
523,erection-supporting medication,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
524,ergot,DB00201,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,C8H10N4O2
525,ergot alkaloid class,None,None,None
526,ergot alkaloid drugs,None,None,None
527,ergot alkaloids,DB01049,None,None
528,ergot-type medications,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
529,ergot-type oxytocic drugs,None,None,None
530,estrogen antagonist,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
531,estrogen-containing compounds,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
532,fat soluble vitamins,None,None,None
533,fat-soluble vitamins,None,None,None
534,fibrate,DB00636,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,C12H15ClO3
535,fibrate drugs,None,None,None
536,fluoroquinolone antibiotic,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
537,fluoroquinolone antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
538,fluoroquinolones,DB09526,C1=CC(=CC=C1O)O,C6H6O2
539,folic acid antagonists,DB00158,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,C19H19N7O6
540,ganglion blockers,DB00649,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO,C10H12N2O4
541,ganglionic adrenergic blocking drugs,DB00649,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO,C10H12N2O4
542,ganglionic blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
543,glucocorticoid,DB00588,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,C25H31F3O5S
544,glucocorticoids,None,None,None
545,glycosides,DB11365,C1=CC2=C(C(=C1)OC3C(C(C(C(O3)CO)O)O)O)C(=O)C4=C(C2C5C6=C(C(=CC=C6)OC7C(C(C(C(O7)CO)O)O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)C(=O)O,C42H38O20
546,gold,DB14154,[Au],Au
547,gold medication,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
548,halogenated hydrocarbon anesthetics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
549,halogenated hydrocarbon general anesthetics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
550,highly active antiretroviral,DB00495,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],C10H13N5O4
551,histone deacetylase inhibitor,DB02565,CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCC(=O)NO,C16H25N3O3
552,hormonal contraceptive,None,None,None
553,hormonal contraceptive agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
554,hydantoin,DB00252,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,C15H12N2O2
555,hydantoin antiepileptic,None,None,None
556,hydantoins,None,C1C(=O)NC(=O)N1,None
557,hydroxymethylglutaryl coenzyme a (hmg-coa) reductase inhibitors,DB00778,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,C41H76N2O15
558,hypnotic,DB09536,O=[Ti]=O,O2Ti
559,hypnotic agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
560,hypnotic drugs,None,None,None
561,hypoglycemic,None,None,None
562,hypoglycemic medications,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
563,hypotensive agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
564,hypotensive drugs,None,None,None
565,imidazole,DB03366,C1=CN=CN1,C3H4N2
566,imidazole antifungals,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
567,imidazole compounds,DB00819,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C4H6N4O3S2
568,imidazole drugs,DB00819,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C4H6N4O3S2
569,immuno-suppressant,None,None,None
570,immunodepressant,None,None,None
571,immunomodulating drugs,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
572,immunosuppressive,None,None,None
573,inactivated vaccines,DB00898,CCO,C2H6O
574,indanedione anticoagulants,None,None,None
575,influenza virus vaccine,DB10781,None,None
576,insulins,None,None,None
577,interferon,DB00008,None,None
578,interleukin,DB00004,None,C2560H4042N678O799S17
579,interleukin-1 antagonist,None,None,None
580,iodine,DB00898,CCO,C2H6O
581,iodine-containing compounds,DB00898,CCO,C2H6O
582,iron supplement,DB00115,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](/C(=C(/C7=N/C(=C\C8=N/C(=C(\C4=N5)/C)/[C@H](C8(C)C)CCC(=O)N)/[C@H]([C@]7(C)CC(=O)N)CCC(=O)N)\C)/[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],C63H88CoN14O14P
583,kappa-selective opioids,DB11130,None,None
584,laxative,DB04348,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,C26H45NO7S
585,live attenuated vaccines,DB00937,CCN(CC)C(C)C(=O)C1=CC=CC=C1,C13H19NO
586,live organism vaccines,None,None,None
587,live typhoid vaccines,DB14022,None,None
588,live-attenuated vaccines,DB00937,CCN(CC)C(C)C(=O)C1=CC=CC=C1,C13H19NO
589,long-acting benzodiazepine,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
590,long-acting benzodiazepines,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
591,long-acting nitrates,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
592,low molecular weight heparins,DB01109,None,None
593,lung surfactant,DB06415,None,None
594,macrolide antibacterials,DB00778,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,C41H76N2O15
595,macrolide class,DB00778,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,C41H76N2O15
596,macrolide immunosuppressant,DB00778,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,C41H76N2O15
597,magnesium,DB14513,[Mg],H2Mg
598,magnesium sparing diuretics,DB14513,[Mg],H2Mg
599,major tranquilizers,DB00683,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,C18H13ClFN3
600,metoclopramide,DB01233,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,C14H22ClN3O2
601,minerals,DB00115,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](/C(=C(/C7=N/C(=C\C8=N/C(=C(\C4=N5)/C)/[C@H](C8(C)C)CCC(=O)N)/[C@H]([C@]7(C)CC(=O)N)CCC(=O)N)\C)/[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],C63H88CoN14O14P
602,mixed agonist/antagonist analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
603,monoamine oxi-dase inhibitors,None,None,None
604,monoamine oxidase inhibiting drugs,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
605,monoamine oxidase inhibitor,None,None,None
606,monoamine oxidase inhibitors (mao-is) type b,None,None,None
607,mu-selective opioids,DB11130,None,None
608,multi minerals,None,None,None
609,multi-minerals,None,None,None
610,multivitamin preparations,DB00115,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](/C(=C(/C7=N/C(=C\C8=N/C(=C(\C4=N5)/C)/[C@H](C8(C)C)CCC(=O)N)/[C@H]([C@]7(C)CC(=O)N)CCC(=O)N)\C)/[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],C63H88CoN14O14P
611,muscle relaxant,DB00423,COC1=CC=CC=C1OCC(COC(=O)N)O,C11H15NO5
612,muscle relaxant drugs,DB09287,None,None
613,muscle relaxants,DB09287,None,None
614,myocardial depressants,DB00756,C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl,C13H6Cl6O2
615,narcotic,None,None,None
616,narcotic analgesic,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
617,nasal vasoconstrictor,DB00388,CNC[C@@H](C1=CC(=CC=C1)O)O,C9H13NO2
618,neuroleptics,None,None,None
619,nitrate,DB14049,[N+](=O)([O-])[O-],NO3
620,nitric oxide donor compounds,DB00435,[N]=O,NO
621,nitrites,DB12529,N(=O)[O-],NO2
622,nitrosourea,DB00262,C(CCl)NC(=O)N(CCCl)N=O,C5H9Cl2N3O2
623,non- steroidal anti- inflammatory agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
624,non- steroidal antiinflammatory agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
625,non-depolarising muscle relaxant,DB00452,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N,C23H46N6O13
626,non-depolarizing muscle relaxants,DB00452,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N,C23H46N6O13
627,non-nucleoside reverse transcriptase inhibitor,None,None,None
628,non-opioid analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
629,non-potassium sparing diuretics,DB14500,[K],K
630,non-selective mao inhibitor,None,None,None
631,non-selective beta-adrenergic-blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
632,non-steroidal anti-inflammatory,None,None,None
633,non-steroidal anti-inflammatory agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
634,non-steroidal anti-inflammatory drug,None,None,None
635,non-steroidal antiinflammatory drugs,None,None,None
636,nonbarbiturate hypnotics,DB08844,C12=C(NC(=O)N1)NC(=O)NC2=O,C5H4N4O3
637,nondepolarizing agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
638,nondepolarizing neuromuscular blocking agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
639,nonsteroial anti-inflammatory drugs,None,None,None
640,nonsteroidal anti inflammatory drug,None,None,None
641,nonsteroidal anti-inflammatory,None,None,None
642,nonsteroidal anti-inflammatory drug,None,None,None
643,nonsteroidal antiinflammatories,None,None,None
644,nonsteroidal antiinflammatory agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
645,opiate,DB06774,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC,C18H27NO3
646,opiate analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
647,opiates,None,None,None
648,opioid,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
649,opioid agonist analgesic,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
650,opioid analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
651,organic nitrates,DB14049,[N+](=O)([O-])[O-],NO3
652,organophosphorous compound,DB14151,P,P
653,oxytocic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
654,oxytocic drugs,None,None,None
655,oxytocics,None,None,None
656,penicillins,None,None,None
657,peripheral adrenergic blocking drugs,None,None,None
658,peripheral vasoconstrictors,DB06711,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,C14H14N2
659,peripherally restricted opioid antagonist,DB11130,None,None
660,phenothiazine,DB11447,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,C12H9NS
661,phenothiazine derivatives,DB00207,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,C38H72N2O12
662,phenothiazine-type tranquilizers,DB00207,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,C38H72N2O12
663,phenothiazines classes of antipsychotic agents,DB00207,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,C38H72N2O12
664,phenylalkylamine,None,None,None
665,phenylbutazone,DB00812,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,C19H20N2O2
666,photosensitizing agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
667,platelet aggregation inhibitors,None,None,None
668,polyene antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
669,polymyxin,DB00027,C[C@@H](C(=O)N[C@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC7=CNC8=CC=CC=C87)C(=O)NCCO)NC(=O)[C@@H](CC(C)C)NC(=O)CNC(=O)[C@H](C(C)C)NC=O,C96H135N19O16
670,polymyxins,None,CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)[C@@H](C)O)CCN)CCN)[C@@H](C)O,None
671,potassium depleting diuretics,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
672,potassium sparing diuretics,DB14500,[K],K
673,potassium- sparing diuretics,DB14500,[K],K
674,potassium-sparing antihypertensives,DB14500,[K],K
675,progestational contraceptives,None,None,None
676,progestin,DB01431,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(CC=C)O)CCC4=CCCC[C@H]34,C21H32O
677,progestin-only oral contraceptives,DB01431,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(CC=C)O)CCC4=CCCC[C@H]34,C21H32O
678,progestins,DB01431,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(CC=C)O)CCC4=CCCC[C@H]34,C21H32O
679,progestogens,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
680,prolonged narcotics,DB01086,CCOC(=O)C1=CC=C(C=C1)N,C9H11NO2
681,prostaglandin synthetase inhibitors,DB00649,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO,C10H12N2O4
682,prothrombin complex concentrates,DB11300,None,None
683,psychostimulants,None,None,None
684,psychotropic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
685,psychotropic drug,None,None,None
686,psychotropic drugs,None,None,None
687,psychotropic medications,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
688,psychotropics,None,None,None
689,pulmonary surfactant,None,None,None
690,pure agonist opioid analgesic,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
691,pyrazolones,DB00819,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C4H6N4O3S2
692,quinidine,DB00908,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,C20H24N2O2
693,quinolone,DB04580,CN1C(=O)C=CC2=CC=CC=C21,C10H9NO
694,quinolone anti-infectives,DB09526,C1=CC(=CC=C1O)O,C6H6O2
695,quinolone antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
696,quinolone antimicrobial,DB00898,CCO,C2H6O
697,quinolone class,DB09526,C1=CC(=CC=C1O)O,C6H6O2
698,quinolone class antimicrobial,DB00898,CCO,C2H6O
699,radiographic iodinated contrast media,DB00554,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,C15H13N3O4S
700,radiopharmaceutical,None,None,None
701,rauwolfia alkaloid,DB09363,None,None
702,retinoids,None,CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C,None
703,reverse transcriptase inhibitors,None,None,None
704,rifamycins,DB11753,C[C@H]1/C=C/C=C(\C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,C37H47NO12
705,salicylate analgesics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
706,second generation (atypical) antipsychotic agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
707,sedating drugs,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
708,sedative hypnotics,None,None,None
709,selective ca(2+) channel blockers,None,None,None
710,selective mao inhibitor,None,None,None
711,selective serotonin reuptake inhibitor,DB08839,C1=CC2=C(C=C1O)C(=CN2)CCN,C10H12N2O
712,serotonin reuptake inhibitor drug,DB08839,C1=CC2=C(C=C1O)C(=CN2)CCN,C10H12N2O
713,serotonin reuptake inhibitors,DB08839,C1=CC2=C(C=C1O)C(=CN2)CCN,C10H12N2O
714,serotoninergic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
715,sex steroids,None,None,None
716,short-acting  beta2-agonists,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
717,short-acting beta adrenergic aerosol bronchodilators,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
718,short-acting nitrates,DB00525,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,C19H17NOS
719,skeletal-muscle relaxants,DB09287,None,None
720,somatostatin analog,DB00318,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,C18H21NO3
721,somatostatin analogs,DB00318,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,C18H21NO3
722,statin,DB00104,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O,None
723,steroid,DB00297,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,C18H28N2O
724,steroid medications,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
725,steroid medicine,None,None,None
726,steroidal anti-inflammatory agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
727,succinimides,DB13376,C1CC(=O)NC1=O,C4H5NO2
728,sulfonamide,DB00214,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,C16H20N4O3S
729,sulfonamide antibiotics,DB00626,CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,C66H103N17O16S
730,sulfonamide drug,None,None,None
731,sulfonylurea,DB00839,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2,C14H21N3O3S
732,sulfonylurea agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
733,sulfonylurea agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
734,sulfonylurea oral hypoglycemic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
735,sulphonylureas,DB03904,C(=O)(N)N,CH4N2O
736,sympathomimetic,None,None,None
737,sympathomimetic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
738,sympathomimetic amine,None,None,None
739,sympathomimetic bronchodilators,DB12846,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O,C18H23N5O5
740,sympathomimetic drugs,None,None,None
741,sympathomimetic medication,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
742,sympathomimetic pressor amines,None,None,None
743,synthetic 3-hydroxy-3-methylglutaryl coenzyme a (hmgcoa) reductase inhibitor,DB00778,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,C41H76N2O15
744,synthetic estrogens,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
745,synthetic steroidal estrogen,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
746,synthetic steroidal progestogen,DB04574,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,C18H22O5S
747,synthetic steroids,None,None,None
748,tetracyclic antidepressants,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
749,tetracycline class,DB00759,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,C22H24N2O8
750,tetracycline class drugs,DB00759,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,C22H24N2O8
751,therapeutic monoclonal antibodies,DB06815,C1=CC(=S)N(C=C1)O,C5H5NOS
752,thiazide,DB00177,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O,C24H29N5O3
753,thiazide diuretic,None,None,None
754,thiazide-like diuretics,None,None,None
755,thiazide-type diuretics,None,None,None
756,thiazolidinediones,DB00812,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,C19H20N2O2
757,thienobenzodiazepine derivative,DB12537,C1=CC=C2C(=C1)C=CC=NN2,C9H8N2
758,thioxanthene classes of antipsychotic agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
759,thioxanthenes,None,None,None
760,thioxanthines,DB02134,C1=NC2=C(N1)C(=O)NC(=O)N2,C5H4N4O2
761,thrombolytics,None,None,None
762,thyroid drugs,DB00279,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,C15H12I3NO4
763,thyroid hormone,DB00279,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,C15H12I3NO4
764,thyroid preparation,DB00279,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,C15H12I3NO4
765,thyroid products,DB00279,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,C15H12I3NO4
766,tranquillisers,DB00683,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,C18H13ClFN3
767,triazole antifungals,DB00257,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C22H17ClN2
768,triazolobenzodiazepines,DB00819,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C4H6N4O3S2
769,tricyclic,None,None,None
770,tricyclic anti-depressants,None,None,None
771,tricyclic antidepressant,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
772,tricyclic antidepressant agent,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
773,tricyclic antidepressant class,DB00458,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,C19H24N2
774,tricyclic drugs,None,None,None
775,tricyclics,None,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,None
776,uricosuric medication,DB06266,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2
777,uricosurics,None,None,None
778,vaccine,DB00045,None,C1198H2012N322O422S2
779,vasoconstrictor agents,DB00381,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C20H25ClN2O5
780,vasoconstrictor drugs,DB06711,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,C14H14N2
781,vasopressor drugs,None,None,None
782,vitamin d analogues,DB00153,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,C28H44O
783,vitamin d preparations,DB00153,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,C28H44O
784,vitamin k antagonists,DB01022,CC1=C(C(=O)C2=CC=CC=C2C1=O)C/C=C(\C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C,C31H46O2
785,vitamin supplements,DB05830,C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@@H]3[C@@H]1[C@@H]4CC[C@@H]([C@]4(CC3)C)O,C19H28O2
786,vitamin-d,None,None,None
787,vitamins,DB00115,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](/C(=C(/C7=N/C(=C\C8=N/C(=C(\C4=N5)/C)/[C@H](C8(C)C)CCC(=O)N)/[C@H]([C@]7(C)CC(=O)N)CCC(=O)N)\C)/[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],C63H88CoN14O14P
788,volatile inhalation anesthetics,DB00281,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C14H22N2O
789,warfarin-type anticoagulant,DB00682,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,C19H16O4
790,warfarin-type anticoagulants,DB00682,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,C19H16O4
791,xanthine bronchodilators,DB02134,C1=NC2=C(N1)C(=O)NC(=O)N2,C5H4N4O2
792,xanthine derivatives,DB02134,C1=NC2=C(N1)C(=O)NC(=O)N2,C5H4N4O2
